Does Tylenol Cause Autism?

What the Research Reports

A number of observational studies over the past decade have reported associations between prenatal acetaminophen exposure and later diagnoses of autism spectrum disorder. Observational studies can flag a possible signal, but they cannot by themselves prove that one thing caused another, because the groups being compared often differ in other ways. People take acetaminophen for reasons, such as fever or infection, that may themselves be relevant, and family genetics play a major role in autism.

The Sibling-Control Study That Complicated the Picture

A large study published in 2024 used a sibling-control design, comparing siblings with different prenatal acetaminophen exposure within the same families. When shared genetic and family factors were accounted for in that way, the previously reported association largely disappeared. Studies like this are important because they help separate the drug from the underlying reasons people use it. The result does not end the debate on its own, but it is a significant reason mainstream scientific bodies have been cautious about claiming causation.

"Associated With" Is Not "Caused By"

This is the central point. An association means a condition appears somewhat more often in a more-exposed group; causation means the exposure actually produced the outcome. Untangling the two here is genuinely hard because of confounding factors like the reason for use, genetics, and other exposures. This is the same distinction at the heart of the litigation, and it is why courts have focused so heavily on the reliability of the scientific testimony.

What the Courts Decided

In the consolidated federal litigation, a judge held a Daubert hearing, which assesses whether expert testimony is scientifically reliable enough to go to a jury, and excluded all five of the plaintiffs' causation experts. With the causation evidence excluded, the court granted summary judgment for the defendants and dismissed the federal cases. The plaintiffs appealed, and that appeal is pending before the Second Circuit. Separately, some claims continue in state courts. For the legal overview, see Tylenol Autism Lawsuits.

The 2025 Government Statement

In September 2025, the U.S. Department of Health and Human Services released a report highlighting reported associations, and federal officials announced steps including a directive for the FDA to pursue a label change. At the same time, the FDA has stated that a causal relationship has not been established. These developments raised the profile of the issue without resolving the underlying scientific question.

Where That Leaves Things

For a parent or expectant parent, the practical takeaway is that the science is contested and evolving, and that medical decisions should be made with a qualified provider rather than from headlines. For the research detail, see The Tylenol Autism Studies, Explained; for the related ADHD question, see Tylenol, Acetaminophen, and ADHD.